{"id":32325,"date":"2013-01-03T19:03:43","date_gmt":"2013-01-04T00:03:43","guid":{"rendered":"http:\/\/countingpips.com\/fx\/?p=32325"},"modified":"2013-01-03T19:03:44","modified_gmt":"2013-01-04T00:03:44","slug":"video-analyst-moves-biib-geva","status":"publish","type":"post","link":"https:\/\/www.investmacro.com\/fx\/2013\/01\/03\/video-analyst-moves-biib-geva\/","title":{"rendered":"VIDEO: Analyst Moves: BIIB, GEVA"},"content":{"rendered":"<p><div id=\"grabDiv1767162\"><script language=\"javascript\" type=\"text\/javascript\" src=\"http:\/\/player.grabnetworks.com\/js\/Player.js?id=1767162&#038;content=vc7e85e536d02da30a6a20c4e0396c7fef10c34ab&#038;width=542&#038;height=304&#038;tgt=grabnetworks\"><\/script><\/p>\n<div id=\"overlay-adzone\" style=\"overflow:hidden; position:relative\"><\/div>\n<\/div>\n<p>Biogen Idec (BIIB) was downgraded by Piper Jaffray (PJC) to neutral from overweight, as the share price has been approacing the previously set $168 price target. Shares are lower by about 1.3 percent.<\/p>\n<p><img src='http:\/\/images.grab-media.com\/market_news\/2013\/01\/03\/ID201301DOWNGRADES010312_thumb.jpg' \/><\/p>\n<p><!--post_img[http:\/\/images.grab-media.com\/market_news\/2013\/01\/03\/ID201301DOWNGRADES010312_preview.jpg]--><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Biogen Idec (BIIB) was downgraded by Piper Jaffray (PJC) to neutral from overweight, as the share price has been approacing the previously set $168 price target. Shares are lower by about 1.3 percent.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-32325","post","type-post","status-publish","format-standard","hentry"],"_links":{"self":[{"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/posts\/32325","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/comments?post=32325"}],"version-history":[{"count":0,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/posts\/32325\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/media?parent=32325"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/categories?post=32325"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/tags?post=32325"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}